• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

After Dobbs, 42 Percent of Surveyed Abortion Providers in Abortion-Ban States Relocated

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on June 17, 2025.

TUESDAY, June 17, 2025 -- Following the Dobbs v Jackson Women’s Health Organization (2022) decision, 42 percent of surveyed clinicians who provided abortions in states banning abortion relocated to another state, almost all to states not banning abortion, according to a research letter published online June 11 in JAMA Network Open.

Dana Howard, Ph.D., from The Ohio State University College of Medicine in Columbus, and colleagues recruited clinicians who provided abortion the year before Dobbs and/or at the time of the survey to examine the proportion of abortion-providing clinicians who changed their primary state of practice.

The analytic sample included 305 respondents. The researchers found that 91 percent of respondents reported providing some nonabortion health care. Overall, 74 and 26 percent of participants practiced in no-ban states and ban states before Dobbs, respectively. Forty-seven respondents (16 percent) relocated their primary practice state; clinicians practicing in states that would ban abortion were much more likely to relocate than those in no-ban states (27 versus 20 respondents [42 versus 9 percent]). Most of those who relocated from ban states relocated to no-ban states (89 percent of 27 respondents). Most of those who relocated from no-ban states relocated to another no-ban state (90 percent of 20 respondents). Six percent of respondents stopped providing any abortion care after Dobbs.

"Given that most study respondents provided both abortion and nonabortion health care, these accelerated relocations have implications for abortion access and for the broader maternal health workforce, exacerbating health care deserts and outcome disparities," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted June 2025

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.